| Identification | More | [Name]
Atropine sulfate monohydrate | [CAS]
5908-99-6 | [Synonyms]
ALPHA-(HYDROXYMETHYL)BENZENEACETIC ACID 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER MONOHYDRATE
ATROPINE SULFATE
ATROPINE SULFATE MONOHYDRATE
ATROPINE SULFATE SALT MONOHYDRATE
ATROPINE SULPHATE MONOHYDRATE
ATROPINI SULFAS
HYOSCYAMINE SULFATE
TROPINE TROPATE MONOHYDRATE
TROPINI SULFAS
Atropsiol
atropine sulfate crystalline
ATROPINE SULFATE MONOHYDRATE, PH EUR
AtropineSulphateGrPuriss
AtropineSulphateB.P.ExAtropaBelladonna
Atropinesulfatemonohydrate,98%
ATROPINE SULFATE 1-HYDRATE
ATROPINE SULFATE 1-HYDRATE, POWDER, PHARMA
Atropine sulfate monohydrate, 98.50%
Benzeneacetic acid, .alpha.-(hydroxymethyl)-(3-endo)-8-methyl-8-azabicyclo3.2.1oct-3-yl ester, sulfate (2:1) (salt), monohydrate
ATROPINESULFATE,MONOHYDRATE,CP | [EINECS(EC#)]
200-235-0 | [Molecular Formula]
C17H27NO8S | [MDL Number]
MFCD00074815 | [Molecular Weight]
405.46 | [MOL File]
5908-99-6.mol |
| Chemical Properties | Back Directory | [Appearance]
Crystalline Solid | [Melting point ]
189-192 °C (A)(lit.)
| [alpha ]
-0.6 º (per USP 25 ºC) | [storage temp. ]
Poison room | [solubility ]
H2O: soluble2.5g/mL (stable for several days at 4°C.) | [form ]
Powder | [color ]
white | [Water Solubility ]
soluble | [Sensitive ]
Light Sensitive | [Usage]
Mydriatic; antispasmodic; used in preanesthetic medication. | [Merck ]
14,875 | [BRN ]
6109275 | [Stability:]
Hygroscopic | [LogP]
2.137 (est) | [CAS DataBase Reference]
5908-99-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
T+ | [Risk Statements ]
R26/28:Very Toxic by inhalation and if swallowed .
R43:May cause sensitization by skin contact.
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S23:Do not breathe gas/fumes/vapor/spray (appropriate wording to be specified by the manufacturer) .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S1:Keep locked up .
S25:Avoid contact with eyes . | [RIDADR ]
UN 1544 6.1/PG 2
| [WGK Germany ]
2
| [RTECS ]
CK2455000 | [F ]
3-8-10 | [TSCA ]
Yes | [HazardClass ]
6.1 | [PackingGroup ]
II | [HS Code ]
29339900 |
| Hazard Information | Back Directory | [Chemical Properties]
Crystalline Solid | [Uses]
Anticholinergic;Muscarinic antagonist | [Uses]
Atropine sulfate is mydriatic; antispasmodic; used in preanesthetic medication.
| [Uses]
mydriatic and anticholinergie agent in ophthalmie preparations and pre-anesthetie medications; antidote to organophosphous
insecticides | [Application]
| [Application]
Atropine sulfate monohydrate(5908-99-6) is an alkaloid derived from belladonna, a cholinergic receptor antagonist drug, which has been shown to be a competitive non-selective antagonist of central and peripheral mAChR M (muscarinic acetylcholine receptor). It can be used in the treatment of cardiac arrhythmias. Atropine Sulfate is also used as a pharmaceutical reference standard for a variety of analytical applications.
| [Brand name]
Atrophate [Veterinary]
(Schering-Plough Animal Health); Atropisol
(Ciba Vision, US Ophthalmics); Isopto Atropine (Alcon). | [General Description]
Atropine is isolated from Atropa belladonna, Datura stramonium and Mandragora officinarum. It is a tertiary amine, which acts as a cholinergic receptor antagonist. | [Biological Activity]
atropine(5908-99-6) is a competitive antagonist of muscarinic acetylcholine receptor with ic50 values of 2.22±0.60nm, 4.32±1.63nm, 4.16±1.04nm, 2.38±1.07nm and 3.39±1.16nm for m1, m2, m3, m4 and m5, respectively [1].atropine is an antimuscarinic agent and has shown the pharmacological effects because of binding to muscarinic acetylcholine receptors. atropine, the orthosteric antagonist, has been reported to compete with [3h]-nms for all muscarinic subtypes with a potency consistent with the high affinities at the machr subtypes. the ki values are 1.27±0.36nm, 3.24±1.16nm, 2.21±0.53nm, 0.77±0.43nm and 2.84±0.84nm, respectively [1, 2, 3].
| [References]
[1] lebois ep1, bridges tm, lewis lm, dawson es, kane as, xiang z, jadhav sb, yin h, kennedy jp, meiler j, niswender cm, jones ck, conn pj, weaver cd, lindsley cw. discovery and characterization of novel subtype-selective allosteric agonists for the investigation of m(1) receptor function in the central nervous system.acs chem neurosci. 2010;1(2):104-121.
[2] busch h, allen h, anderson dc.effects of atropine and carbachol on labeling of protein fractions of mouse pancreas in vitro.j pharmacol exp ther. 1959 nov; 127:200-4.
[3] feron o1, smith tw, michel t, kelly ra.dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. j biol chem. 1997 jul 11; 272(28):17744-8. |
|
|